4-bromo-Resveratrol

CAS No. 1224713-90-9

4-bromo-Resveratrol( —— )

Catalog No. M23395 CAS No. 1224713-90-9

4'-bromo-Resveratrolis a potent inhibitor of the deacetylases sirtuin 1 (SIRT1) and 3 (SIRT3).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 71 In Stock
5MG 65 In Stock
10MG 104 In Stock
25MG 217 In Stock
50MG 346 In Stock
100MG 555 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-bromo-Resveratrol
  • Note
    Research use only, not for human use.
  • Brief Description
    4'-bromo-Resveratrolis a potent inhibitor of the deacetylases sirtuin 1 (SIRT1) and 3 (SIRT3).
  • Description
    4'-bromo-Resveratrolis a potent inhibitor of the deacetylases sirtuin 1 (SIRT1) and 3 (SIRT3).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    SIRT1|SIRT3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1224713-90-9
  • Formula Weight
    291.14
  • Molecular Formula
    C14H11BrO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.George J , Nihal M , Singh C K , et al. 4′‐Bromo‐resveratrol, a dual Sirtuin‐1 and Sirtuin‐3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming[J]. Molecular Carcinogenesis, 2019, 58.
molnova catalog
related products
  • UBCS039

    UBCS039 (UBCS-039) is the first synthetic activator of the NAD+-dependent protein lysine deacetylase SIRT6 with EC50 of 38 uM.

  • MZ-242

    A novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM.

  • EX 527 (Selisistat)

    EX 527 is a potent and selective SIRT1 inhibitor with IC50 of 38 nM, exhibits >200-fold selectivity against SIRT2 and SIRT3.